Session Chair: Max Cummings, Johnson & Johnson
Monday, 09 February 2015, from 14:00 to 17:00
Showcase the use of structure based drug design in overcoming ADME-related challenges in drug discovery, foster discussion of any areas of perceived low-hanging fruit for the application of SBDD to ADME issues.
Session Chair: Lance Westeroff, Quantum Bio
Tuesday, 10 February 2015, from 09:00 to 12:00
Thanks to a surge in availability of linear scaling algorithms, improved models, and faster hardware, there has been greater use of quantum mechanics and mixed-QM/MM methods in all areas of structure based drug discovery.